Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.39
-0.06 (-1.10%)
Apr 29, 2026, 10:13 AM EDT - Market open
Quoin Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -15.8 | -8.96 | -8.69 | -9.38 | -21.46 | |
| Depreciation & Amortization | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Other Amortization | - | - | - | - | 0.28 | |
| Asset Writedown & Restructuring Costs | - | - | 0.02 | - | - | |
| Loss (Gain) From Sale of Investments | -0.22 | -0.25 | -0.49 | -0.09 | - | |
| Stock-Based Compensation | 1.15 | 1.26 | 1.09 | 0.76 | - | |
| Other Operating Activities | - | - | - | 0.22 | 14.73 | |
| Change in Accounts Payable | 1.33 | 0.28 | 0.05 | -0.22 | 1.35 | |
| Change in Other Net Operating Assets | -0.09 | -0.28 | 0.04 | 0.12 | -0.72 | |
| Operating Cash Flow | -13.54 | -7.86 | -7.86 | -8.48 | -5.72 | |
| Investment in Securities | -4.28 | -1.89 | 2.19 | -9.9 | - | |
| Other Investing Activities | - | - | - | -0.25 | -0.63 | |
| Investing Cash Flow | -4.28 | -1.89 | 2.19 | -10.15 | -0.63 | |
| Short-Term Debt Issued | - | - | - | - | 3.48 | |
| Long-Term Debt Issued | - | - | - | - | 0.14 | |
| Total Debt Issued | - | - | - | - | 3.61 | |
| Short-Term Debt Repaid | - | - | - | -0.31 | - | |
| Long-Term Debt Repaid | -0.6 | -0.6 | -0.6 | -0.6 | -0.3 | |
| Total Debt Repaid | -0.6 | -0.6 | -0.6 | -0.91 | -0.3 | |
| Net Debt Issued (Repaid) | -0.6 | -0.6 | -0.6 | -0.91 | 3.31 | |
| Issuance of Common Stock | 18.61 | 11.57 | 5.85 | 14.88 | 10.1 | |
| Other Financing Activities | - | - | -0.03 | 0.04 | 0.09 | |
| Financing Cash Flow | 18.01 | 10.97 | 5.22 | 14.01 | 13.5 | |
| Foreign Exchange Rate Adjustments | -0 | - | - | - | - | |
| Net Cash Flow | 0.19 | 1.22 | -0.46 | -4.62 | 7.16 | |
| Cash Interest Paid | - | - | - | - | 0.39 | |
| Levered Free Cash Flow | -7.96 | -4.28 | -4.68 | -6.21 | -7.63 | |
| Unlevered Free Cash Flow | -7.96 | -4.28 | -4.68 | -5.77 | -7.06 | |
| Change in Working Capital | 1.23 | -0 | 0.1 | -0.09 | 0.63 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.